News & analysis on the clinical development and manufacture of large molecule drugs
Oxford Genetics: Jocelyne Bath
By Maggie Lynch
- Last updated on
Jocelyne Bath will take on the role of chief operating officer at the Oxfordshire-based synthetic biology-based technologies company. Bath has extensive experience working in science and engineering technology sectors. Prior to joining Oxford Genetics, she was chief revenue officer at EYOTO, an eye care technology company, and previous to that, VP of commercial strategy for P2i a company focusing in liquid repellent nano-coating technology.
She has additional experience in product, revenue, and commercial management from holding roles in product pricing and analysis leading to strategic commercial management.
At Oxford Genetics, Bath will be responsible for commercial positioning and business operations.
Bath commented on her appointment to this role, “Oxfordshire is a fantastic center for science and technology, I’m delighted to be part of the Oxford Genetics team and looking forward to the journey ahead. I’ve joined at an exciting time, with innovative solutions, a strong team and sound backing, Oxford Genetics has a bright future.”